← Back to guidelines
Hematology7 papers

Hemoglobin H disease

Last edited: 4/15/2026

Overview

Hemoglobin H (HbH) disease is a form of α-thalassemia characterized by the presence of HbH and HbA, resulting from the inheritance of two α-globin gene deletions or mutations, typically leaving one functional α-globin gene per cell 2.

Diagnosis

  • Hemoglobin Electrophoresis: Essential for identifying HbH and quantifying HbA, HbH, and other abnormal hemoglobins 2.
  • Molecular Analysis: Recommended for identifying specific α-thalassemia mutations such as -3.7α, -4.2α, and -SEA mutations 2.
  • Complete Blood Count (CBC): Often shows microcytic anemia with hypochromia 2.
  • Peripheral Blood Smear: May reveal target cells and nucleated red blood cells 2.
  • Management

  • Supportive Care: Regular monitoring of hemoglobin levels and management of anemia with iron supplementation if iron deficiency coexists 2.
  • Blood Transfusions: Indicated for severe anemia or acute hemolytic crises 2.
  • Hydroxyurea: Not typically recommended for HbH disease but may be considered in specific cases of ineffective erythropoiesis 2.
  • Special Populations

  • Pregnancy: Requires close monitoring of maternal and fetal well-being; may necessitate transfusions for severe anemia 2.
  • Pediatrics: Early diagnosis and management crucial to prevent developmental delays due to chronic anemia 2.
  • Elderly: Similar management principles apply, with emphasis on managing complications like cardiovascular strain from chronic anemia 2.
  • Key Recommendations

  • Perform hemoglobin electrophoresis and molecular analysis for α-thalassemia mutations in patients with unexplained microcytic anemia 2 (Evidence: Strong).
  • Implement regular monitoring and supportive care including iron supplementation if indicated 2 (Evidence: Moderate).
  • Consider blood transfusions for managing severe anemia or acute hemolytic episodes 2 (Evidence: Moderate).
  • References

    1 Belton J, Hoens A, Scott A, Ardern CL. Patients as Partners in Research: It's the Right Thing to Do. The Journal of orthopaedic and sports physical therapy 2019. link 2 Dastidar R, Gajra B, De M. Molecular and hematological characterization of hemoglobin H disease in the Bengali population of Kolkata, India. Genetic testing and molecular biomarkers 2011. link

    Original source

    1. [1]
      Patients as Partners in Research: It's the Right Thing to Do.Belton J, Hoens A, Scott A, Ardern CL The Journal of orthopaedic and sports physical therapy (2019)
    2. [2]
      Molecular and hematological characterization of hemoglobin H disease in the Bengali population of Kolkata, India.Dastidar R, Gajra B, De M Genetic testing and molecular biomarkers (2011)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG